Sannemann, Lena http://orcid.org/0000-0003-1072-9375
Schild, Ann-Katrin
Altenstein, Slawek
Bartels, Claudia
Brosseron, Frederic
Buerger, Katharina
Cosma, Nicoleta Carmen
Fliessbach, Klaus
Freiesleben, Silka Dawn
Glanz, Wenzel
Heneka, Michael T.
Janowitz, Daniel
Kilimann, Ingo
Kobeleva, Xenia
Laske, Christoph
Metzger, Coraline D.
Munk, Matthias H. J.
Perneczky, Robert
Peters, Oliver
Polcher, Alexandra
Priller, Josef
Rauchmann, Boris
Rösch, Christina
Rudolph, Janna
Schneider, Anja
Spottke, Annika
Spruth, Eike Jakob
Teipel, Stefan
Vukovich, Ruth
Wagner, Michael
Wiltfang, Jens
Wolfsgruber, Steffen
Duezel, Emrah
Jessen, Frank
,
Funding for this research was provided by:
Deutsches Zentrum für Neurodegenerative Erkrankungen (BN012)
Article History
Received: 22 June 2020
Accepted: 2 October 2020
First Online: 16 October 2020
Ethics approval and consent to participate
: The study protocol was approved by the ethical committees of the medical faculties of all participating sites: the ethical committees of Berlin (Charité, Universitätsmedizin Berlin), Bonn, Cologne, Göttingen, Magdeburg, Munich (Ludwig-Maximilians-University), Rostock, and Tübingen. The process was led and coordinated by the ethical committee of the medical faculty of the University of Bonn. The registration number of the trial at the ethical committee in Bonn is 117/13. All participants provided written informed consent.
: Not applicable.
: The authors declare that they have no competing interests with regard to the content of the manuscript.